Soranib 200 mg ( Sorafenib ) 120 film-coated tablets
Therapeutic indications:
Hepatocellular carcinoma
Soranib is indicated for the treatment of hepatocellular carcinoma.
Renal cell carcinoma
Soranib is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
Differentiated thyroid carcinoma
Soranib is indicated for the treatment of patients with progressive, locally advanced or metastatic, differentiated (papillary/follicular/H?rthle cell) thyroid carcinoma, refractory to radioactive iodine.
Reviews
There are no reviews yet.